Challenges on Multiple Endpoints in Clinical Trials: An Industry Survey in Japan

被引：0
|
作者：
Kentaro Sakamaki
Seitaro Yoshida
Yusuke Morita
Toshifumi Kamiura
Katsuhiro Iba
Naoyuki Ogawa
Hideki Suganami
Satoru Tsuchiya
Satoru Fukimbara
机构：
[1] The University of Tokyo,Department of Biostatistics and Bioinformatics
[2] Yokohama City University,Center for Data Science
[3] Japan Pharmaceutical Manufacturers Association,Data Science Expert Committee, Drug Evaluation Committee
[4] Chugai Pharmaceutical Co,Clinical Information & Intelligence Department
[5] Ltd,Clinical Data Science and Affairs
[6] Kyorin Pharmaceutical Co,Data Science Department
[7] Ltd,Department of Biometrics
[8] Nippon Shinyaku Co,Clinical Development Department
[9] Ltd,Clinical Data Science Department
[10] Otsuka Pharmaceutical Co,Data Science
[11] Ltd,Data Science
[12] Sanwa Kagaku Kenkyusho Co,undefined
[13] Ltd,undefined
[14] Kowa Company,undefined
[15] Ltd,undefined
[16] Sumitomo Dainippon Pharma Co,undefined
[17] Ltd,undefined
[18] Ono Pharmaceutical Co,undefined
[19] Ltd,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2020年 / 54卷
关键词：
multiple endpoints; terminology; determination of endpoint; multiplicity adjustment; industry survey;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：528 / 533
页数：5
相关论文
共 50 条
  • [31] Imaging endpoints in clinical trials
    Garhofer, G.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [32] Endpoints for clinical trials in ophthalmology
    Schmetterer, Leopold
    Scholl, Hendrik
    Garhoefer, Gerhard
    Janeschitz-Kriegl, Lucas
    Corvi, Federico
    Sadda, Srinivas R.
    Medeiros, Felipe A.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2023, 97
  • [33] Endpoints in cancer clinical trials
    Fiteni, F.
    Westeel, V.
    Pivot, X.
    Borg, C.
    Vernerey, D.
    Bonnetain, F.
    JOURNAL OF VISCERAL SURGERY, 2014, 151 (01) : 17 - 22
  • [34] Economic Endpoints in clinical trials
    Hlatky, MA
    EPIDEMIOLOGIC REVIEWS, 2002, 24 (01) : 80 - 84
  • [35] Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes
    Renard, D
    Geys, H
    Molenberghs, G
    Burzykowski, T
    Buyse, M
    BIOMETRICAL JOURNAL, 2002, 44 (08) : 921 - 935
  • [36] Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials
    Zhang, Zhiwei
    Wang, Chenguang
    Troendle, James F.
    STATISTICS IN MEDICINE, 2015, 34 (09) : 1467 - 1482
  • [37] Endpoints of clinical trials in oncology
    Roila, F
    Del Favero, A
    Ballatori, E
    TUMORI JOURNAL, 1997, 83 (06): : S8 - S13
  • [38] Economic endpoints in clinical trials
    Cook, J
    Drummond, M
    Heyse, JF
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (02) : 157 - 176
  • [39] CLINICAL TRIALS WITH BIOLOGICAL ENDPOINTS
    Roth, A. D.
    ANNALS OF ONCOLOGY, 2012, 23 : 37 - 37
  • [40] Design and analysis of group sequential clinical trials with multiple primary endpoints
    Kosorok, MR
    Shi, YJ
    DeMets, DL
    BIOMETRICS, 2004, 60 (01) : 134 - 145
12345